ERLOTINIB SANDOZ 150 mg, comprimé pelliculé — plaquette(s) aluminium OPA : polyamide orienté PVC de 30 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930142271
  • CIP7 3014227
  • CIS 64452922

What the source publishes

Holder
SANDOZ
Active ingredients
CHLORHYDRATE D'ERLOTINIB, ERLOTINIB
Form
comprimé pelliculé
Package
plaquette(s) aluminium OPA : polyamide orienté PVC de 30 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
Marketing status
Déclaration de commercialisation
Authorised on
2018-03-12
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930142271
{
  "cis": "64452922",
  "cip7": "3014227",
  "form": "comprimé pelliculé",
  "name": "ERLOTINIB SANDOZ 150 mg, comprimé pelliculé — plaquette(s) aluminium OPA : polyamide orienté PVC de 30 comprimé(s)",
  "cip13": "3400930142271",
  "holder": "SANDOZ",
  "routes": [
    "orale"
  ],
  "holders": [
    "SANDOZ"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "851.04",
  "authorisedOn": "2018-03-12",
  "compositions": [
    {
      "name": "CHLORHYDRATE D'ERLOTINIB",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "27387",
      "dosageReference": null,
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "ERLOTINIB",
      "nature": "FT",
      "strength": "150 mg",
      "linkageNumber": "1",
      "substanceCode": "56421",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
  "dispensingFee": "1.02",
  "medicinePrice": "850.02",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "ERLOTINIB SANDOZ 150 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) aluminium OPA : polyamide orienté PVC de 30 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "100 %"
  ],
  "marketingDeclaredOn": "2020-03-23",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "CHLORHYDRATE D'ERLOTINIB",
    "ERLOTINIB"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
    "prescription réservée aux spécialistes et services HEMATOLOGIE",
    "prescription hospitalière",
    "liste I",
    "prescription réservée aux médecins compétents en CANCEROLOGIE"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930142271"